Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
51,68 USD | +0,98% | -1,23% | -17,65% |
24/04 | INCYTE CORPORATION : Een koopadvies van Oppenheimer | ZM |
23/04 | Transcript : Escient Pharmaceuticals, Inc., Incyte Corporation - M&A Call |
Omzet 2024 * | 4,13 mld. 3,86 mld. | Omzet 2025 * | 4,59 mld. 4,29 mld. | Marktkapitalisatie | 11,49 mld. 10,75 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 797 mln. 745 mln. | Nettowinst (verlies) 2025 * | 991 mln. 927 mln. | EV/omzet 2024 * | 1,72 x |
Nettoliquiditeiten 2024 * | 4,37 mld. 4,09 mld. | Nettoliquiditeiten 2025 * | 5,68 mld. 5,31 mld. | EV/omzet 2025 * | 1,27 x |
K/w-verhouding 2024 * |
15
x | K/w-verhouding 2025 * |
11,8
x | Werknemers | 2.524 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 98,41% |
Recentste transcriptie over Incyte Corporation
1 dag | +0,70% | ||
1 week | -1,47% | ||
Lopende maand | -9,46% | ||
1 maand | -8,79% | ||
3 maanden | -14,94% | ||
6 maanden | -4,96% | ||
Lopend jaar | -17,85% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Herve Hoppenot
CEO | Chief Executive Officer | 64 | 13-01-14 |
Director of Finance/CFO | 53 | 11-02-19 | |
Pablo Cagnoni
PSD | President | 60 | 05-06-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Julian Baker
BRD | Director/Board Member | 57 | 01-01-01 |
Edmund Harrigan
BRD | Director/Board Member | 71 | 16-12-19 |
Director/Board Member | 70 | 20-01-15 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
14.55% | 215 M€ | +10,80% | - | |
2.94% | 1 M€ | 0,00% | - | |
2.88% | 1 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 51,68 | +0,98% | 989 618 |
25-04-24 | 51,18 | -1,08% | 1 771 950 |
24-04-24 | 51,74 | +0,17% | 1 564 434 |
23-04-24 | 51,65 | -0,52% | 2 493 676 |
22-04-24 | 51,92 | -0,82% | 1 751 676 |
uitgestelde koers Nasdaq, 26 april 2024 om 19:55 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-17,85% | 11,49 mld. | |
-4,66% | 87,53 mld. | |
+1,32% | 40,42 mld. | |
-19,06% | 29,48 mld. | |
+57,86% | 25,43 mld. | |
-43,00% | 11,3 mld. | |
-9,14% | 11,1 mld. | |
+5,24% | 8,75 mld. | |
-8,42% | 7,99 mld. | |
+1,24% | 7,67 mld. |